JHFH5 Mar 2024 12:00
JHFH, I think you are a great poster and on the whole speak a lot of sense, clearly have a good understanding of what Hemo are trying to do, the board is a better place with you on it.
I do however think you have to accept that Hemo could have been managed much better from the BOD.
The science looks and appears to be superb, time will tell but certainly sounds as though it could really help the medical world.
The share price should have been much higher than where it is now, it all started to go wrong with the Mint debacle and quite frankly has never recovered, to go clinical and do a placing at 2p is a very poor result, as you have said many times, find another clinical company with a market cap as low as Hemo, surely that tells you what a poor job the BOD have done from a business perspective, a new CEO with vast amounts of business experience should have been brought in quite some time ago, if they had I am not sure we would have been sitting at under 2p a share!!.
Hopefully the science wins the day, which I am hopeful it will.
GLA